Tyroservaltide
Tier C — Watch / tradeTyroservaltide
Targets：HDAC
Indications (approved)：Non-small cell lung cancer
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| YSV-001 | 3262-72-4 | (tert-butoxycarbonyl)-L-serine |
| YSV-002 | 6306-52-1 | methyl L-valinate hydrochloride |
| YSV-003 | 139167-67-2 | methyl (tert-butoxycarbonyl)-L-seryl-L-valinate |
| YSV-004 | 162285-31-6 | methyl L-seryl-L-valinate hydrochloride |
| YSV-005 | 3978-80-1 | (S)-2-((tert-butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoic acid |
| YSV-006 | 934476-37-6 | methyl (tert-butoxycarbonyl)-L-tyrosyl-L-seryl-L-valinate |
| YSV-007 | - | (tert-butoxycarbonyl)-L-tyrosyl-L-seryl-L-valine |
Frequently asked questions
What are the approved indications of Tyroservaltide?
Approved indications include: Non-small cell lung cancer.
When does the Tyroservaltide patent expire?
No public expiry year is available for Tyroservaltide yet; this page updates once verified.
How many synthesis routes are recorded for Tyroservaltide?
1 synthesis routes are recorded; the shortest is 5 steps with 37 g total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Tyroservaltide intermediates?
All intermediates in Tyroservaltide routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Tyroservaltide intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-12